Steve Dahlberg

Follow

Generating author description...

Common Coauthors
Commonly Cited References
Action Title Year Authors # of times referenced
+ Sample size and power determination for stratified clinical trials 1978 David P. Bernstein
Stephen W. Lagakos
2
+ The asymptotic properties of nonparametric tests for comparing survival distributions 1981 David Schoenfeld
1
+ A Leisurely Look at the Bootstrap, the Jackknife, and Cross-Validation 1983 Bradley Efron
Gail Gong
1
+ Testing Against Ordered Alternatives for Censored Survival Data 1993 P. Y. Liu
Stephanie Green
Michael Wolf
John Crowley
1
+ One-Sample Multiple Testing Procedure for Phase II Clinical Trials 1982 Thomas R. Fleming
1
+ The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent 1961 Edmund A. Gehan
1
+ Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial 1975 Stuart J. Pocock
Richard Simon
1
+ Optimal two-stage screening designs for survival comparisons 1990 Daniel J. Schaid
Sam Wieand
Terry M. Therneau
1
+ The Analysis of Variance 1960 Henry Scheffe
1
+ Choosing covariates in the analysis of clinical trials 1989 Michael L. Beach
Paul Meier
1
+ Sample size requirements for comparing time-to-failure among k treatment groups 1982 Robert Makuch
Richard Simon
1
+ PDF Chat Optimal two-stage designs for phase II clinical trials 1989 Richard Simon
1
+ Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation 1981 Larry Rubinstein
Mitchell H. Gail
Thomas J. Santner
1
+ PDF Chat A Single-Sample Multiple Decision Procedure for Ranking Means of Normal Populations with known Variances 1954 Robert E. Bechhofer
1
+ Martingale-based residuals for survival models 1990 Terry M. Therneau
Patricia M. Grambsch
T. R. FLEMING
1
+ Two-stage selection and testing designs for comparative clinical trials 1988 Peter F. Thall
Richard Simon
Susan S. Ellenberg
1
+ Covariate adjustment of treatment effects in clinical trials 1991 Paul L. Canner
1
+ Data monitoring committees and early stopping guidelines: The southwest oncology group experience 1994 John Crowley
S. Green
P. Y. Liu
Michael Wolf
1
+ Simultaneous Statistical Inference 1981 Rupert G. Miller
1
+ PDF Chat A Large Sample Study of Cox's Regression Model 1981 Anastasios A. Tsiatis
1
+ Designs for Group Sequential Phase II Clinical Trials 1987 M N Chang
Terry M. Therneau
H. Samuel Wieand
S. Stephen
1
+ PDF Chat Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma 1992 Leo I. Gordon
David Harrington
Janet Andersen
Joseph P. Colgan
John H. Glick
Richard S. Neiman
Risa B. Mann
Gene Resnick
Maurice Barcos
Arlan J. Gottlieb
1
+ Some Diagnostic Methods for Cox Regression Models Through Hazard Smoothing 1990 Robert J. Gray
1
+ Randomized phase II clinical trials. 1985 Richard Simon
R. Wittes
Susan S. Ellenberg
1
+ How large should a phase II trial of a new drug be? 1987 Ronald Simon
1
+ PDF Chat Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67 1988 TM Grogan
Lippman Sm
CM Spier
DJ Slymen
JA Rybski
Rangel Cs
L Richter
TP Miller
1
+ The American Statistician 1947 1
+ Drug activity and therapeutic synergism in cancer treatment. 1982 Walter H. Carter
Galen L. Wampler
Donald M. Stablein
Eleanor D. Campbell
1
+ Partial likelihood 1975 D. R. Cox
1